News

Allergan is talking with Sanofi and Johnson & Johnson about whether they want to counter an unsolicited $45.7 billion offer from Valeant Pharmaceuticals to acquire Allergan, according to news reports from Bloomberg.com.

French pharmaceutical company Pierre Fabre has received marketing authorization from the Food and Drug Administration for the oral drug Hemangeol (propranolol hydrochloride) for the treatment of infantile hemangioma.

Skin grown in a lab from human stem cells could help to eliminate the need to test drugs and cosmetics on animals, according to recent research.

It’s no secret - the number of fillers available in the United States doesn’t quite measure up to the products being marketed in other countries. Accessible or not, it’s important for U.S. physicians to keep an eye on what is out of their reach, according to Patrick Trevidic, M.D., in Paris, and Vince Bertucci, M.D., in Toronto.

Medicare’s payment data dump has sparked backlash from physician advocate groups, including the American Medical Association and the American College of Physicians, who argue that releasing the information without context is misleading.

La Roche-Posay has announced the recipients of the ninth annual La Roche-Posay North American Foundation 2014 Research Awards, celebrating advances in clinical, biological and pharmacological research advances in the field of dermatology.

Dermatologists are less likely to prescribe generic drugs when they are provided with samples of brand name drugs to give to their patients, a new study suggests.

Hereditary hair loss affects millions of men and women, but with more research, treatments are improving. Neil Sadick, M.D., a dermatologist in New York City, will be speaking about the advances in hair loss and treatments at the 2014 Vegas Cosmetic Surgery and Aesthetic Dermatology meeting in June.

Dermatology residents not only commit medical errors and witness others do the same, but they often fail to report the errors or take steps to prevent them, results of a new study suggest.

Video education tools aimed at men boost attendance at whole-body clinical skin examinations and enhances men’s awareness of skin health concerns, a recent study indicates.

A low-energy, low-density 1,440 nm fractional laser is effective for treating photodamage in Asian patients, according to results of a small study.

Patients who take the erectile dysfunction treatment Viagra (sildenafil citrate, Pfizer) are at an increased risk of developing melanoma, recent research suggests.

Children with atopic dermatitis (AD), or eczema, don’t necessarily grow out of the disease, as was previously believed, according to a new study.

An investigational drug being studied for the treatment of melanoma has demonstrated a decrease of melanoma cells in both injected tumors and non-injected bystander tumors in mice.

Teenagers who use indoor tanning devices may be at greater risk for harmful weight control behaviors, according to results of a recent study.

Michael Gold, M.D., discusses lasers and light-based technology with Dermatology Times. Watch the video for a PROMO CODE for a 10 percent discount on VCS 2014 registration.

A study that used histology and three-dimensional imaging of hyaluronic acid fillers in a mouse model reveals that lifting capacity depends on more than G prime.

A patient recovering from surgery was warned about the possibility of infection, and she develops an infection that leads to sepsis. Should the physician have explained to her that infection could lead to sepsis and possibly death, and can the physician be sued?

Suboptimal reconstitution of botulinum toxin type A preparations can diminish the efficacy of neuromodulators for cosmetic use.

To maintain a leadership position in aesthetic treatments, core specialists must identify and embrace the game-changing innovations of the future, says an expert. To that end, he recommends participating in drug and device development and clinical trials.

There is evidence of how light or laser therapy may stimulate hair growth, according to an expert who spoke at a dermatology symposium about the facts and myths of laser and light therapy.

Regardless of the specialty, one commonality that has resulted from the multitudinous technologic advances and the improved quality and quantity of life is that they have all come at a significant cost.

Photodynamic therapy applied every other month shows promise as a chemopreventive regimen, while thermal PDT appears to offer better photosensitizer uptake and long-term results than standard PDT, experts say.

For years, cosmetic chemists have been looking for the mechanism whereby the skin remains naturally moisturized, and it has recently been identified.

The “Chaos & Clues” decision algorithm allows physicians to decide for or against biopsy at the speed of a normal examination, without making complex calculations, one of its developers says.

As researchers learn more about the pathogenesis of rosacea, they can better understand the benefits of certain medications and find opportunities for new therapies.

In treating nonmelanoma skin cancers, an expert says, superficial radiation therapy appears poised for a resurgence due to factors including its safety, efficacy and cost-effectiveness.

Oral terbinafine has been the gold standard for treatment of onychomycosis for more than 20 years, but development of new therapeutic options has been the focus of some significant research activity.

Dermatologists can expect to see highly effective systemic and oral therapeutic options for psoriasis and psoriatic arthritis added to their toolbox.

Captive insurance companies can help physicians manage financial risks, reduce taxable income by hundreds of thousands of dollars per year, and build a side fund to help manage future changes.